|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 23 of 24 found articles
| Title: |
VP5-2023: Primary results from BEATcc (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030), a randomised phase III trial of first-line atezolizumab (atezo) combined with a platinum doublet and bevacizumab (bev) for metastatic (stage IVB), persistent or recurrent cervical cancer (R/M CC) |
| Author: |
Oaknin, A. Gladieff, L. Martinez-Garcia, J. Villacampa, G. Takekuma, M. De Giorgi, U.F.F. Lindemann, K. Woelber, L. Colombo, N. Duska, L.R. Leary, A. Godoy Ortiz, A. Nishio, S. Angelergues, A. Rubio Perez, M.J. Fariñas Madrid, L. Yamaguchi, S. Lorusso, D. D'Hondt, V. Randall, L. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 34 () nr. 12 pages 1198-1200 |
| Year: |
2023 |
| Contents: | |
| Publisher: |
Published by Elsevier B.V. |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 23 of 24 found articles
| << previous | next >> |